Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ)
Your view on SUSRF
Overview
What the company does, where it operates, and who runs it.
About Surgical Science Sweden AB (publ)
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Tom Englund
- Headquarters
- Drakegatan 7 A, 3 tr., Gothenburg, SE
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Tom Englund
- Headquarters
- Drakegatan 7 A, 3 tr., Gothenburg, SE
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator.
The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators.
Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Surgical Science Sweden AB (publ), and the rating behind it. SUSRF last traded at $2.84, 27.8× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Surgical Science Sweden AB (publ). Starting points for Surgical Science Sweden AB (publ): P/E 27.8, EPS $1.83, beta 0.52 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Surgical Science Sweden AB (publ). Surgical Science Sweden AB (publ) does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Surgical Science Sweden AB (publ). Trailing twelve-month EPS for Surgical Science Sweden AB (publ) stands at $1.83. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Surgical Science Sweden AB (publ). Surgical Science Sweden AB (publ) has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Surgical Science Sweden AB (publ) valued side by side against its closest peers. Surgical Science Sweden AB (publ) is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Surgical Science Sweden AB (publ), and how their positions are changing. At a $144.9M market value, institutional positions materially move Surgical Science Sweden AB (publ)'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Surgical Science Sweden AB (publ) executives and directors. Shares of Surgical Science Sweden AB (publ) have traded between $2.84 and $16.33 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Surgical Science Sweden AB (publ). Surgical Science Sweden AB (publ) is a $144.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Surgical Science Sweden AB (publ). Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Surgical Science Sweden AB (publ). Coverage tracks Surgical Science Sweden AB (publ) within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.